Sinopharm Group Co. Ltd. (SHTDF)

PNK: SHTDF · Real-Time Price · USD

2.35

-0.15 (-6.00%)

At close: Apr 28, 2025, 12:26 PM

Sinopharm Balance Sheet Statement

Financials in CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	54.31B	63.81B	55.22B	43.53B	50.18B	39.19B	40.3B	29.01B	25.57B
Short-Term Investments	158K	547K	498K	11.75M	39.14M	156K	41.2M	175.61M	5.47M
Long-Term Investments	10.89B	10.55B	9.84B	9.17B	8.45B	7.86B	7.02B	5.53B	4.05B
Other Long-Term Assets	3.5B	7.94B	3.73B	3.73B	3.95B	3.51B	2.83B	2.51B	5.75B
Receivables	206.72B	189.79B	171.2B	172.58B	146.05B	122.63B	106.68B	81.3B	70.73B
Inventory	62.35B	60.03B	60.93B	51.5B	47.09B	42.59B	35.39B	26.77B	25.76B
Other Current Assets	14.05B	12.17B	187.77B	185.97B	159.5B	137.25B	117.55B	89.98B	77.8B
Total Current Assets	347.45B	336.84B	319.41B	290.92B	267.61B	230B	204.65B	144.84B	132.76B
Property-Plant & Equipment	17.61B	18.05B	17.79B	17.6B	17.07B	16.27B	12.69B	9.14B	8.08B
Goodwill & Intangibles	10.97B	10.02B	12.03B	12.2B	12.56B	10.8B	7.5B	6.67B	6.28B
Total Long-Term Assets	45.38B	46.56B	45.37B	44.49B	43.63B	39.89B	31.12B	24.7B	24.95B
Total Assets	392.83B	383.39B	364.78B	335.41B	311.24B	269.89B	235.77B	169.54B	157.71B
Account Payables	156.87B	154.75B	144.62B	132.87B	116.73B	108.92B	87.72B	75.54B	68.86B
Deferred Revenue	n/a	n/a	28B	21.62B	22.87B	17.42B	15.95B	8.69B	7.45B
Short-Term Debt	62.73B	54.73B	53B	55.15B	54.96B	42.48B	50.09B	31.65B	22.36B
Other Current Liabilities	16.57B	17.52B	21.95B	17.73B	18.88B	15.98B	14.43B	-3.97B	2.92B
Total Current Liabilities	250.38B	241.49B	234.96B	219.31B	203.98B	178.42B	160.07B	110.88B	99.74B
Long-Term Debt	8.64B	13.83B	11.75B	8.42B	8.92B	8.37B	4.95B	5.45B	11.14B
Other Long-Term Liabilities	2.82B	4.33B	4.79B	4.78B	5.15B	3.05B	2.4B	633.53M	2.31B
Total Long-Term Liabilities	15.77B	21.59B	19.74B	16.45B	17.31B	14.52B	7.42B	7.39B	13.44B
Total Liabilities	266.14B	263.08B	254.71B	235.76B	221.29B	192.95B	167.5B	118.27B	113.18B
Total Debt	76.39B	73.78B	69.59B	68.37B	68.53B	55.14B	55.1B	35.69B	33.5B
Common Stock	3.12B	3.12B	3.12B	3.12B	3.12B	2.97B	2.97B	2.77B	2.77B
Retained Earnings	53.74B	49.41B	42.87B	38.52B	32.91B	27.59B	23.09B	21.1B	13.44B
Comprehensive Income	n/a	n/a	-4.39B	-4.39B	-4.31B	-4.3B	-4.33B	-3.45B	-3.19B
Shareholders Equity	78.88B	74.58B	68.07B	61.89B	56.36B	47.42B	42.82B	35.26B	31.81B
Total Investments	10.89B	10.55B	9.84B	9.18B	8.48B	7.86B	7.07B	5.7B	4.06B